Stanley T Lewis
Overview
Explore the profile of Stanley T Lewis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
137
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pham R, Pham-Hoang A, Lewis S, Greenway F, Dessouki A, Grimes R
J Diabetes Complications
. 2023 Aug;
37(9):108549.
PMID: 37540985
We followed two patients with diabetic retinopathy over the course of their treatment with physiologic Insulin resensitization. Both patients showed improvement of their diabetic retinopathy, after treatment.
2.
Lewis S, Greenway F, Tucker T, Alexander M, Jackson L, Hepford S, et al.
Int J Mol Sci
. 2023 Jul;
24(13).
PMID: 37446104
Physiologic insulin secretion consists of an oscillating pattern of secretion followed by distinct trough periods that stimulate ligand and receptor activation. Apart from the large postprandial bolus release of insulin,...
3.
Greenway F, Loveridge B, Grimes R, Tucker T, Alexander M, Hepford S, et al.
Int J Mol Sci
. 2022 Feb;
23(3).
PMID: 35163806
Prevalence of type 2 diabetes increased from 2.5% of the US population in 1990 to 10.5% in 2018. This creates a major public health problem, due to increases in long-term...
4.
Gathe J, Hardwicke R, Garcia F, Weinheimer S, Lewis S, Cash R
J Acquir Immune Defic Syndr
. 2021 Jan;
86(4):482-489.
PMID: 33427765
Ibalizumab, a humanized monoclonal antibody targeting CD4, blocks HIV-1 entry into cells and is the first Food and Drug Adminstration-approved long-acting agent for HIV-1 treatment. In this phase 2a study,...
5.
Fessel W, Anderson B, Follansbee S, Winters M, Lewis S, Weinheimer S, et al.
Antiviral Res
. 2011 Oct;
92(3):484-7.
PMID: 22001594
The availability of 24 antiretroviral (ARV) drugs within six distinct drug classes has transformed HIV-1 infection (AIDS) into a treatable chronic disease. However, the ability of HIV-1 to develop resistance...
6.
Toma J, Weinheimer S, Stawiski E, Whitcomb J, Lewis S, Petropoulos C, et al.
J Virol
. 2011 Feb;
85(8):3872-80.
PMID: 21289125
Ibalizumab (formerly TNX-355) is a first-in-class, monoclonal antibody inhibitor of CD4-mediated human immunodeficiency type 1 (HIV-1) entry. Multiple clinical trials with HIV-infected patients have demonstrated the antiviral activity, safety, and...
7.
Hardwicke R, Lewis S, Grimes R
J Assoc Nurses AIDS Care
. 2010 Mar;
21(5):429-38.
PMID: 20303794
Dyslipidemia is common in persons living with HIV infection. Nurse clinicians must be able to recognize lipid abnormalities so that treatment plans can be developed. Managing dyslipidemia must be considered...
8.
Jacobson J, Kuritzkes D, Godofsky E, DeJesus E, Larson J, Weinheimer S, et al.
Antimicrob Agents Chemother
. 2008 Nov;
53(2):450-7.
PMID: 19015347
Ibalizumab (formerly TNX-355) is a humanized monoclonal antibody that binds CD4, the primary receptor for human immunodeficiency virus type 1 (HIV-1), and inhibits the viral entry process. A phase lb...
9.
Hardwicke R, Malecha A, Lewis S, Grimes R
J Assoc Nurses AIDS Care
. 2008 May;
19(3):211-8.
PMID: 18457762
The purpose of this study was to determine the effective use of the 2001 Centers for Disease Control and Prevention (CDC) HIV testing recommendations in emergency department settings. A postal...
10.
Grimes R, Lewis S, Visnegarwala F, Goodly J, Sutton R, Rodriguez-Barradas M
HIV Clin Trials
. 2003 Apr;
4(2):92-8.
PMID: 12671776
Background: Studies have shown that reverse transcription-polymerase chain reaction (RT-PCR) technology underquantifies viral loads in patients with non-B clades of HIV-1. Testing with bDNA technology gave higher viral loads in...